Clinical Trials Browser

Phase 2 × Uveal Melanoma × cixutumumab × Clear all

NCT01413191 2020-02-19

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Phase 2 Completed

18 enrolled 9 charts

Uveal Melanoma